Depression and quality of life in patients with Multiple Sclerosis

The aim of the present study was to determine the relationship between the quality of life and depression by using SF-36 quality of life scale in MS patients. Forty-eight patients who were certainly diagnosed with MS according to McDonald diagnostic criteria in the Neurology Clinic and were admitted to the Physical Therapy and Rehabilitation Outpatient Clinic between the dates of 2013 and 2015, and a total of 43 age and gender matched healthy controls were included in the study. The short form 36 ve The Beck Depression Inventory(BDI ) were used to determine the clinical condition of the patients. Depression was detected in 36.3% and 11.9% of the MS patients and control group, respectively (p

PDF

___

1. Compston A, Coles A. Multiple sclerosis. Lancet. 2008;372(9648):1502-17.

2. Solaro C, Trabucco E, Messmer Uccelli M. Pain and multiple sclerosis: pathophysiology and treatment. Curr Neurol Neurosci Rep. 2013;13(1):320.

3. Newland PK, Naismith RT, Ullione M. The impact of pain and other symptoms on quality of life in women with relapsing-remitting multiple sclerosis. J Neurosci Nurs. 2009;41(6):322-8.

4. Pugliatti M, Rosati G, Carton H, Riise T, Drulovic J, Vécsei L, Milanov I. The epidemiology of multiple sclerosis in Europe. Euro. J. Neurol. 2006;13(7):700-22.

5. Tutuncu M, Tang J, Zeid NA, Kale N, Crusan DJ, Atkinson EJ, Keegan BM. Onset of progressive phase is an age-dependent clinical milestone in multiple sclerosis. Mult Scler. 2013;19(2):188-98.

6. Motl RW, McAuley E, Snook EM, Scott JA. Validity of Physical Activity Measures in Ambulatory Individuals with Multiple Sclerosis. Disabil Rehabil. 2006;28(18):1151-6.

7. Snook EM, Motl RW. Physical Activity Behaviors in Individuals with Multiple Sclerosis: Roles of Overall and Specific Symptoms, and Self Efficacy. J Pain Symptom Manage. 2008;36(19:46-53.

8. Janardhan V, Bakshi R. Quality of life and its relationship to brain lesion and atrophy on magnetic resonance images in 60 patients with multiple sclerosis. Arch Neurol. 2000;57(10):1485-91.

9. Rothwell PM. Quality of life in multiple sclerosis. J Neurol Neurosurg Psychiatry. 1998;65(4):433.

10. Skokou M, Soubasi E, Gourzis P. Depression in multiple sclerosis: a review of assessment and treatment approaches in adult and pediatric populations. ISRN Neurol. 2012;2012:427102.

11. Garfield AC, Lincoln NB. Factors affecting anxiety in multiple sclerosis, Disabil. Rehabil. 2012;34(24):2047–52.

12. Espinola-Nadurille M, Colin-Piana R, Ramirez-Bermudez J, LopezGomez M, Flores J, Arrambide G, Corona T. Mental disorders in Mexican patients with multiple sclerosis. Neuropsychiatry Clin. 2010;22(1):63–9.

13. Galeazzi G, Ferrari S, Giaroli G, Mackinnon A, Merelli E, Motti L, Rigatelli M. Psychiatric disorders and depression in multiple sclerosis outpatients: impact of disability and interferon beta therapy. Neurol. Sci. 2005;26(4):255-62.

14. Marrie RA, Reingold S, Cohen J, Trojano M, Soelberg Sorensen P, Cutter G, Reider N. The incidence and prevalence of psychiatric disorders in multiple sclerosis: a systematic review. Mult. Scler. 2015;21(3):305–17.

15. Honarmand K, Feinstein A. Validation of the hospital anxiety and depression scale for use with multiple sclerosis patients. Mult. Scler. 2009;15(12):1518–24.

16. Korostil M, A. Feinstein A. Anxiety disorders and their clinical correlates in multiple sclerosis patients. Mult. Scler. 2007;13(1):67– 72.

17. Pittion-Vouyovitch S, Debouverie M, Guillemin F, Vandenberghe N, Anxionnat R, Vespignani H. Fatigue in multiple sclerosis is related to disability, depression and quality of life. Journal of the Neurological Sciences. 2006;243(1-2):39-45.

18. D’alisa S, Miscio G, Baudo S, Simone A, Tesio L, Mauroi A. Depression is the main determinant of quality of life in multiple sclerosis: A classification-regression (CART) study. Disability and Rehabilitation. 2006;28(5):307-14.

19. Beck AT, Ward CH, Mendelson M, Mock J, Erbaugh J. An inventory for measuring depression. Arch Gen Psychiatry. 1961;4:561-71.

20. Hisli N. Validity and reliability of Beck Depression Inventory for Turkish university students. J Psychol. 1989;7:3-13.

21. Keller SD, Ware JE Jr, Bentler PM, et al. Use of structural equation modeling to test the construct validity of the SF-36 health survey in ten countries: results from the IQOLA project. International quality of life assessment. J Clin Epidemiol. 1998;51(11):1179-88.

22. Janssens AC, van Doorn PA, de Boer JB, van der Meché FG, Passchier J, Hintzen RQ. Impact of recently diagnosed multiple sclerosis on quality of life, anxiety, depression and distress of patients and partners. Acta Neurol Scand. 2003;108(6):389-95.

23. Nicholl CR, Lincoln NB, Francis VM, Stephan TF. Assessing quality of life in people with multiple sclerosis.Disability and Rehab. 2001;23(14):597-603.

24. O’Connor P, Lee L, Ng PT, Narayana P. Determinants of overall quality of life in secondary progressive MS: a longitudinal study. Neurology. 2001;57(5):889-91.

25. Nortvedt MW, Riise T, Myhr KM, Nyland HI. Quality of life in multiple sclerosis. Measuring the disease effects more broadly. Neurology.1999; 53(5):1098-103.

26. Pati F, Cacopardo M, Palermo F, Ciancio MR, Lopes R, Restivo D, Reggio A. Health-related quality of life and depression in an Italian sample of multiple sclerosis patients. Journal of the Neurological Sciences. 2003;211(1-2):55–6

27. McHorney CA, Ware JJ, Raczek AE. The MOS 36-Item Short Form Health Survey (SF-36): II. Psychometric and clinical tests of validity in measuring physical and mental health constructs. Medical Care. 1993;31(3):247-63.

28. Dalgas U, Stenager E, Sloth M. The effect of exercise on depressive symptoms in multiple sclerosis based on a meta‐analysis and critical review of the literature Eur J Neurol. 2015;22(3):443-34.

29. Gay MC, Vrignaud P, Garitte C, Meunier C. Predictors of depression in multiple sclerosis patients. Acta Neurol. Scand.2010;121 (3):161– 70.

30. Chwastiak L, Ehde DM, Gibbons LE, Sullivan M, Bowen JD, Kraft GH. Depressive symptoms and severity of illness in multiple sclerosis: epidemiological study of a large community sample. Am. J. Psychiatry.2002;159(11):1862–8.

31. Ayuso-Mateos, Jose Luis, Vázquez-Barquero, Jose Luis, Dowrick, Christopher, Lehtinen,Ville, Odd Steffen, Dalgard, Patricia, Casey, Graham, Dunn. Depressive disorders in Europe: prevalence figures from the ODIN study. Br. J. Psychiatry .2001;79(4):308-16.

32. Sadovnik AD. Depression and multiple sclerosis. Neurology. 1996;46(3):628-32.

33. Simpson S, Tan H, Otahal P, Taylor B, Ponsonby A-L, Lucas RM, Blizzard L, Valery PC, Lechner-Scott J, Shaw C, Williams D, van der Mei I. Anxiety, depression and fatigue at 5-year review following CNS demyelination. Acta Neurol Scand. 2016:134(6):403-13.

34. Moore P, Hırst C, Hardıng KE, Clarkson H, PIckersgıll TP, Robertson NP. Multiple sclerosis relapses and depression. J Psychosom Res. 2012;73(4):272–6.

35. Jones KH, Ford DV, Jones PA, John A, Middleton RM, LockhartJones H, Osborne LA, Noble JG. A large-scale study of anxiety and depression in people with Multiple Sclerosis: a survey via the web portal of the UK MS Register. PLoS One. 2012;7(7):419-10.

36. Dennis M, Baillon S, Brugha T, Lindesay J, Stewart R, Meltzer H. The influence of limitation in activity of daily living and physical health on suicidal ideation: results from a population survey of Great Britain. Psychiatric Epidemiol. 2009;44 (8):608-13.

37. Sarısoy G, Terzi M, Gümüş K, Pazvantoğlu O. Psychiatric symptoms in patients with multiple sclerosis. Gen. Hosp. Psychiatry. 2013;35(2):134-40.

38. Turner AP, Williams RM, Bowen JD, Kivlahan DR, Haselkorn JK. Suicidal Ideation in Multiple Sclerosis. Arch. Phys. Med. Rehabil. 2006;87(8):1073-8.